Beta-blocker, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, nitrate-hydralazine, diuretics, aldosterone antagonist, ivabradine, devices and digoxin (BANDAID2): an evidence-based mnemonic for the treatment of systolic heart failure

Beta Blocker ◽

Enzyme Inhibitor ◽

Systolic Heart Failure ◽

Evidence Based ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Aldosterone Antagonist

Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker

Mayo Clinic Proceedings Innovations Quality & Outcomes ◽

10.1016/j.mayocpiqo.2020.10.008 ◽

2021 ◽

Author(s):

Nicholas Y. Tan ◽

Yihong Deng ◽

Xiaoxi Yao ◽

Lindsey R. Sangaralingham ◽

Nilay D. Shah ◽

...

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Systolic Heart Failure ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Prognostic Impact of Angiotensin-converting Enzyme Inhibitor and/or Angiotensin Receptor Blocker in Patients with Diastolic Heart Failure

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2007.06.217 ◽

2007 ◽

Vol 13 (6) ◽

pp. S47

Author(s):

Jun Takahashi ◽

Nobuyuki Shiba ◽

Tomohiro Tada ◽

Hiroaki Shimokawa

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Diastolic Heart Failure ◽

Prognostic Impact ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin‐Converting Enzyme Inhibitor or Angiotensin‐Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure

Journal of the American Heart Association ◽

10.1161/jaha.118.011089 ◽

2019 ◽

Vol 8 (9) ◽

Cited By ~ 4

Author(s):

Nancy M. Albert ◽

Jason P. Swindle ◽

Erin K. Buysman ◽

Chunlan Chang

Keyword(s):

Heart Failure ◽

Retrospective Analysis ◽

Healthcare Costs ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Patients With Heart Failure

Is Combined Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Therapy Safe in Heart Failure Patients?

Hospital Pharmacy ◽

10.1310/hpj4305-362 ◽

2008 ◽

Vol 43 (5) ◽

pp. 362-367

Author(s):

Patricia A. Howard

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Blocker Therapy ◽

Heart Failure Patients ◽

Lower Hospitalization and Total Healthcare Costs Among Patients with Heart Failure When Treated with Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin-Receptor Blocker: A Retrospective Study of Managed Care Claims

Heart & Lung ◽

10.1016/j.hrtlng.2020.02.012 ◽

2020 ◽

Vol 49 (2) ◽

pp. 211

Author(s):

Nancy Albert ◽

Erin Buysman ◽

Chunlan Chang ◽

Jason Swindle

Keyword(s):

Heart Failure ◽

Retrospective Study ◽

Healthcare Costs ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Patients With Heart Failure

Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors

International Journal of Cardiology ◽

10.1016/j.ijcard.2007.10.009 ◽

2008 ◽

Vol 125 (2) ◽

pp. 172-177 ◽

Cited By ~ 9

Author(s):

Soko Setoguchi ◽

Raisa Levin ◽

Wolfgang C. Winkelmayer

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Community Dwelling ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Heart Failure Hospitalization ◽

Long Term Trends

250 The impact of an angiotensin converting enzyme inhibitor or an angiotensin receptor blocker on Doppler-echo diastolic and systolic parameters in heart failure with normal ejection fraction

European Journal of Echocardiography ◽

10.1016/s1525-2167(05)80103-9 ◽

2005 ◽

Vol 6 ◽

pp. S27-S27

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Enzyme Inhibitor ◽

Normal Ejection Fraction ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

The Impact

The Impact of Discontinuation of Sacubitril-Valsartan and Shifting to Angiotensin-Converting Enzyme inhibitor or Angiotensin Receptor Blocker in Patients with Heart Failure with Reduced Ejection Fraction

The Anatolian Journal of Cardiology ◽

10.14744/anatoljcardiol.2020.39267 ◽

2020 ◽

Author(s):

Osama A Amin

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Reduced Ejection Fraction ◽

Patients With Heart Failure ◽

The Impact

“Triple Therapy” of Heart Failure With Angiotensin-Converting Enzyme Inhibitor, Beta-Blocker, and Aldosterone Antagonist May Triple Survival Time

JACC Heart Failure ◽

10.1016/j.jchf.2014.04.012 ◽

2014 ◽

Vol 2 (5) ◽

pp. 545-548 ◽

Cited By ~ 5

Author(s):

Graham D. Cole ◽

Sheetal J. Patel ◽

Nabeela Zaman ◽

Anthony J. Barron ◽

Claire E. Raphael ◽

...

Keyword(s):

Heart Failure ◽

Survival Time ◽

Triple Therapy ◽

Beta Blocker ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Aldosterone Antagonist ◽

Effects of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Therapy After Hospital Discharge on Subsequent Rehospitalization for Acute Myocardial Infarction and Heart Failure

Congestive Heart Failure ◽

10.1111/j.1751-7133.2009.00092.x ◽

2009 ◽

Vol 15 (4) ◽

pp. 170-175 ◽

Cited By ~ 9

Author(s):

Gregory Hess ◽

Ronald Preblick ◽

Jerrold Hill ◽

Craig A. Plauschinat ◽

Joseph Yaskin

Keyword(s):

Myocardial Infarction ◽

Heart Failure ◽

Acute Myocardial Infarction ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Blocker Therapy